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Abstract
In vitro human skin benzene permeation was measured from gasoline formulations with benzene 
concentrations ranging from 0.8 to 10 vol% and from neat benzene. Steady-state fluxes (JSS), 
permeability coefficients (kp) and lag times (tlag) were calculated from infinite dose exposures. 
Permeation of benzene from small gasoline doses administered over a two-day period was also 
studied. The thermodynamic activity of benzene in gasoline at 30°C was determined and the 
solution is near-ideal over the range from 0.8 to 100 vol%. JSS through human epidermal 
membranes were linear (R2 = 0.92) with concentration over the range from 0.8 to 10 vol %. JSS 
(μg/cm2/h) from gasoline (0.8 vol% benzene = 6.99 mg/ml) through epidermis and full-thickness 
skin were 9.37 ± 1.41 and 1.82 ± 0.44, respectively. Neat benzene JSS was 566 ± 138. Less than 
0.25% of the total applied benzene mass from finite doses (10 μl/cm2) of gasoline was detected in 
receptor cells, and a small reduction of barrier function was observed from six total doses 
administered over 2 days. Application of these results to dermal exposure assessment examples 
demonstrates a range of systemic benzene uptakes that can be expected from occupational and 
consumer dermal exposures to gasoline, depending on the type and extent of exposure
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INTRODUCTION
Benzene exposures have been linked to various well-described acute and chronic health 
effects and benzene has been recognized as a human carcinogen by various international 
agencies for over 30 years.1–3 The US EPA1 classifies benzene as a “known” human 
carcinogen (Category A) for all routes of exposure, including the dermal route.
Benzene penetrates the skin following dermal contact. Dermal absorption studies have been 
reported using neat benzene, aqueous benzene and benzene in various organic mixtures, 
including gasoline (summarized by Williams et al.4). These studies demonstrate the capacity 
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to which benzene penetrates the skin and is systemically absorbed. Reported average human 
in vitro steady-state flux (Jss) measurements of neat benzene range from 99 (Lodén5) to 
1855 μg/cm2/h (Blank and McAuliffe6). This nearly 20-fold range in measured values points 
to a need for additional data, and possible methodological issues in both studies can be 
identified. The study by Lodén5 used full-thickness skin, which is not recommended for 
lipophilic compounds,7 in a flow-through diffusion cell system in which receptor medium is 
collected by dripping into open vials in a fraction collector. Vapor losses are to be expected 
in this open system; however, the author took steps to minimize losses and claimed they “did 
not exceed 5%” but did not provide data, and benzene freely permeates through 
polyethylene tubing8 that was used by Lodén. Nevertheless, the data show excellent steady-
state linearity up to 16 h of exposure. The large human epidermis measurement reported by 
Blank and McAuliffe6 has been called into question4,9,10 based on perceived inconsistencies 
in the reported value. Other human flux measurements have been summarized by Williams 
et al.,4 who concluded that a range of neat benzene fluxes from 200 to 400 μg/cm2/h is 
supported. Additional data would be beneficial to add to the weight-of-evidence on neat 
benzene dermal uptake rates.
Thus there is ample evidence that benzene permeates skin, even if a definitive penetration 
rate of neat benzene is not universally agreed upon. There is less research on the permeation 
of benzene from hydrocarbon mixtures, including gasoline. Current EPA regulations11 
stipulate that all gasoline imported and refined for sale in the United States contain benzene 
at ≤ 0.62 vol% on an annual average basis and a maximum content of 1.3 vol%. Historically, 
maximum concentrations close to 9% have been reported in European gasoline with mean 
values of 1–4%,12 while US and North American gasoline has contained approximately 1–
2%.
Despite these more recent reductions, benzene does remain a constituent in gasoline, hence 
the potential for dermal absorption remains. Apparently only two studies have measured in 
vitro benzene permeation from gasoline. Blank and McAuliffe6 studied benzene penetration 
through heat-separated human epidermis from various vehicles including gasoline. Their 
formulation contained 5 vol% benzene (= 50 μl/ml = 43.7 mg/ml; density of benzene = 874 
μg/μl), and the authors reported a Jss of 0.07 ± 0.03 μl/cm2/h (= 61 ± 26 μg/cm2/h). More 
recently, Adami et al.13 measured the in vitro penetration of benzene, toluene and xylenes 
from gasoline through full-thickness human abdominal skin. Benzene concentrations in the 
three tested gasoline formulations ranged from 0.39 to 1.06 wt%, and their measured Jsss 
ranged from 1.47 ± 0.53 to 2.71 ± 1.62 μg/cm2/h. Therefore, the flux measurement of Blank 
and McAuliffe is ~ 30-fold higher than the values by Adami et al., even though benzene 
concentration was only ~ 5-fold higher. This discrepancy has fueled debate over the 
assignment of appropriate flux values for benzene from gasoline.4,14–16
Additional data from a single laboratory using human skin processed in the same manner are 
necessary to fill in the gaps of the existing data and to cover a broader range of benzene 
concentrations that have been used historically. A well-characterized gasoline formulation 
containing 0.8 vol% benzene (“native gasoline”) was used in these in vitro studies. 
Epidermal permeation experiments used this formulation alone and spiked with additional 
benzene up to 10 vol%, as well as neat benzene to determine steady-state fluxes and lag 
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times. To address differences in previously published permeation values, the penetration 
rates of benzene from native gasoline were compared between epidermis and full-thickness 
skin samples. Additionally, we measured the absorption kinetics of benzene from small 
(finite) gasoline doses of 10 μl/cm2 containing 1.8 vol% benzene administered multiple 
times over a two-day period. Finally, we measured the thermodynamic activity of benzene in 
gasoline up to 100% (neat benzene). These new data enable more confident interpolation of 
flux data over the range of benzene concentrations that have been used historically in 
gasoline. This in turn should enhance confidence in both current-use exposure estimates and 
historical benzene exposure reconstructions. Implications of these data within dermal 
exposure assessments are provided with several examples. A subsequent report will present 
permeation results on toluene, ethylbenzene, xylenes and naphthalene from gasoline.
MATERIALS AND METHODS
Chemicals and Solutions
Gasoline reference material (“native gasoline”), supplied in 20 ml sealed glass ampules, was 
purchased from Supelco (Cat. no. 502227; lot LC03300) and stored at 4 °C. The 
accompanying Consensus Analysis reported a benzene concentration of 0.80 vol% (average 
of three determinations using ASTM D3606, D5580 and D5769). An ampule was submitted 
for further characterization to Bureau Veritas North America for analyses by ASTM D5580 
and ASTM D6730 at their Houston Technical Center. Results (Table 1) confirmed a benzene 
concentration of 0.80 vol% (mean of both methods). With a density of 874 mg/ml, the 
benzene concentration in this gasoline is 6.99 mg/ml. Gasoline was transferred to minimal 
headspace Teflon-sealed glass vials, stored at 4 °C, and used within 2 weeks of opening. 
Benzene was from Sigma-Aldrich (Cat. no. 270709, lot SHBF0424V) with reported purity > 
99.9%.
Receptor fluid and buffer were HEPES-buffered Hanks Balanced Salt Solution (Gibco, 
Invitrogen, Carlsbad, California, USA), with 50 mg/l of gentamicin sulfate and 5.96 g/l of 
HEPES (Sigma-Aldrich). The pH of the buffer was adjusted to 7.4 at 37 °C. The buffer was 
filtered (pore sizes: 0.2 μm, SFCA, Nalgene, Thermo Fisher Scientific) and degassed prior to 
use by warming to 40 °C and stirring under laboratory vacuum.
Human Skin Preparation
Human skin was received fresh from the West Virginia University Tissue Bank and was 
processed within 1 day of receipt. The surgical specimens were taken following informed 
consent from eight white females, ages 23–53 years, who had undergone breast reduction 
surgery. Our use of human tissue was deemed “not human research” by WVU and NIOSH 
Human Subject Review Boards. Heat-separated epidermal membranes (HEM) were 
prepared by submersing the skin in buffer at 60 °C for 60 s. Epidermis was separated from 
remaining dermis using cotton swabs. Epidermal discs were cut using a stainless steel punch 
(1.59 cm diameter), floated onto a pool of buffer with 10% glycerol on aluminum foil, 
covered with gauze and stored at − 85 °C. Full-thickness skin was prepared by scraping off 
subcutaneous fat prior to storage as with epidermis. Neither epidermal nor full-thickness 
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skin thicknesses were measured. Skin samples were stored up to 1 year prior to use. We have 
demonstrated retention of barrier properties under these conditions.17
In Vitro Permeation Studies
Franz-type (static) diffusion cells were used (0.64 cm2 diffusion area and 5 ml receptor 
volume, PermeGear, Hellertown, PA, USA). Studies were conducted in a fume hood with 
certified face velocity between 56 and 70 cm/s and conformed to OECD Guidelines7 except 
where noted. To minimize evaporation of benzene and other volatiles, custom (PermeGear) 
threaded glass donor cells were used and sealed with Teflon-septa caps. Sample side arms 
were also sealed with Teflon septa. Skin samples were thawed at room temperature, floated 
on a pool of buffer and mounted on cells with dialysis tubing (MWCO 12–14,000) used as a 
membrane support for HEM. Skin surfaces were rinsed 3 × with water and equilibrated 
overnight with buffer in receptor compartments. The skin surface was open to air and 
maintained at 32 °C by recirculating water at 37 °C through the jacketed cells. Relative 
humidity in the laboratory was not monitored. Studies were performed on 12 skin replicates 
for each formulation. Owing to limited sizes of the surgical specimens, not all experiments 
could be performed from the same human donors. Experiments using gasoline and gasoline 
fortified with up to 5% total benzene were performed on three samples from each of the 
same four individuals. Experiments using gasoline with 10% benzene and neat benzene 
shared three of these four individuals plus one additional. Studies comparing full thickness 
with epidermis were carried out on samples from one individual. Finite dose experiments 
were undertaken using four skin discs from each of the three individual donors who differed 
from those used in the infinite dose studies.
Receptor compartment samples were 0.5 ml and were replaced with fresh buffer. The 
samples were removed with a gas tight Hamilton syringe, placed in precooled 10 ml 
headspace vials, immediately capped and stored on a cooled (4 °C) sample tray until 
analyzed, within 38 h. Tests showed no significant loss of benzene from samples stored up to 
48 h prior to analysis (P > 0.9, Pearson Product Moment Correlation).
Donor Formulations
Donor formulations consisted of native gasoline, gasoline+added benzene and neat benzene. 
None were radiolabeled. Working dilutions of gasoline+benzene were mixed the day of the 
experiment. Benzene was added to gasoline to form total concentrations (vol%) of 2.2, 3.6, 
5.0 and 10. For finite dose studies, benzene was added to facilitate quantification for a total 
concentration of 1.8 vol%.
Infinite Dose Studies
Infinite dose studies permit calculation of steady-state fluxes, permeability coefficients and 
lag times. One thousand microliters of the donor formulation were applied to skin surface 
and donor cells were immediately capped (occluded condition) to inhibit evaporation of the 
volatile components with the goal to maintain a constant benzene concentration. The 
exposure duration for gasoline and gasoline+benzene formulations was 8 h, and receptor 
fluid was sampled at 0, 0.5, 1, 2, 3, 4, 6 and 8 h. For neat benzene, exposure duration was 4 
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h to ensure that benzene concentrations in receptor fluid remained approximately < 10% of 
aqueous solubility.
Finite Dose Studies
Finite dose studies are more representative of common gasoline-related exposure scenarios. 
Doses of 10 μl/cm2 were used, in accordance with OECD guidelines.7 The formulation was 
gasoline with 1.8 vol% benzene (benzene dose 157 μg/cm2). Standard donor cells (internal 
diameter 0.9 cm; height 1.7 cm) were used and were not capped (unoccluded condition) to 
allow for volatile evaporation, which more closely reflects typical exposures. Receptor 
samples were taken at 0, 20, 40, 60 and 120 min, at which point an additional dose was 
added to donor cells, samples were taken and at 240 min, a third dose was added for a total 
exposure sample time of 360 min. The following day, at approximately the same time, the 
three doses were repeated for a total of six exposures. Benzene recovery, recommended in 
the OECD guideline,7 was not determined. To do so would have required the placement of a 
trap above the donor cells that would have lowered the benzene evaporation rate compared 
with that from an open donor cell, with the expected consequence of greater benzene 
absorption.
Benzene Thermodynamic Activity Measurements
The thermodynamic activity of benzene (aBen) in gasoline solution was determined by 
measuring its equilibrium partial pressure relative to that of pure benzene measured at the 
same defined temperature.18,19 Partial pressures were measured at 30 °C using static 
headspace gas chromatography (GC) described below.
Gasoline–benzene solutions were mixed to achieve a specified volume fraction ϕBen (volume 
of benzene divided by total solution volume):
ϕBen =
VBen + 0.008VGas
VBen + VGas
, (1)
where VBen is the volume of added benzene and VGas the volume of gasoline. Results are 
presented as functions of both volume fraction and mole fraction xBen, which was calculated 
as:
xBen =
nBen
nBen + nGas
=
VBen + 0.008VGas ρBen/MWBen
VBenρBen/MWBen + VGasρGas/MWGas
, (2)
where n is the number of moles, ρ is the density (g/ml) and MW is the molecular weight (g/
mole). ρBen is 0.874; MWBen is 78.1; ρGas, measured by us at uncontrolled room 
temperature (~22 °C) is 0.733 and MWGas was taken as an “average value” of 108.20 A total 
of three independent measurements were taken at each ϕBen, except that nine measurements 
were made at ϕBen = 1.
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GC Analysis
Static headspace GC analysis was performed on samples from infinite dose studies and 
thermodynamic activity determinations. The GC system was a Varian 3800 with CombiPal 
autosampler using headspace mode. A flame ionization detector was used and the column 
was a trifluoropropyl-methyl polysiloxane capillary (Restek RTX 200 MS, 30 m length, 0.25 
mm ID, 1 μm thickness) with 1 ml/min of He gas flow. Receptor cell samples were 
incubated at 50 °C for 20 min. Six hundred microliters of headspace was injected with split 
ratio at 10. The oven temperature was isothermal at 60 ° C and benzene retention time was 
5.7 min. Calibrations were linear (R2 > 0.99) over the range of sample values.
For activity measurements, samples were incubated at 30 °C for 30 min prior to injection 
with a split ratio of 50. Activity was calculated as the peak area of the sample, divided by the 
average peak area of the samples of neat benzene.
For finite dose benzene detection, the CombiPal ITEX preparation method of sample 
enrichment was used that repeatedly (20 times) draws a 1000 μl headspace sample through a 
Tenax-coated needle prior to rapid thermal desorption (230 °C) into the GC injector. Highly 
linear (R2 > 0.99) calibrations were obtained with benzene concentrations down to 3 ng/ml.
Calculation of Permeation Parameters
Steady-state fluxes (JSS), permeability coefficients (kp) and lag times (tlag) were calculated 
from infinite dose experimental results. The total amount of chemical that penetrated the 
skin and was absorbed into the receptor fluid, normalized by the area of exposed skin (m(t)), 
was calculated from the measured receptor concentrations at each sample time point, taking 
into account the amount that had been removed with each prior sample. Jss and tlag were 
calculated by nonlinear regression of the experimental data to the solution of the one-
dimensional diffusion equation for a homogeneous membrane initially free of chemical and 
exposed on the outer surface to a constant concentration while sink conditions (zero 
concentration) apply to the inner surface. For each dosed skin sample, the best fit of the data 
to the first seven terms of the solution21 was determined using SigmaPlot 12.5 (Systat 
Software):
m(t) = JSSt − JSStlag − 12
JSStlag
π2
∑
n = 1
∞ ( − 1)n
n2
exp −n2π2 t6tlag
(3)
The analysis yields estimates for the two variables Jss and tlag. The permeability coefficient, 
kp, was calculated as
kp =
JSS
Cd
, (4)
where Cd is the (constant) concentration of benzene in the donor formulation. For neat 
benzene, the concentration was taken as its density (874 mg/ml).
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Fractional absorption of benzene from finite dose exposures was calculated as the total mass 
recovered in receptor cells at 2 h of exposure, divided by the applied benzene dose (both: 
mass/area).
Statistical Tests
The number of replicates for these studies was chosen to exceed OECD guidelines.7 
Preexposure assessment of barrier function was not undertaken. All replicates that were 
mounted on diffusion cells were dosed and all data were included in subsequent analyses 
and statistical tests: no replicates were rejected by post hoc evaluation. Samples were not 
allocated randomly, but replicates from each human donor were chosen haphazardly for 
treatment. The investigator was not blinded either during the experiment or when analyzing 
data. In contrast with commonly used graphical methods to determine steady-state fluxes 
and lag times, the use of Eq. (3) removes subjectivity from this analysis. Statistical tests 
were conducted using SigmaPlot 12.5. Differences between- or among-group means were 
probed using unpaired t-test, one-way analysis of variance or repeated-measures one-way 
analysis of variance. If normality test (Shapiro–Wilk) failed, then a non-parametric analysis 
(Mann–Whitney rank-sum test, Kruskal–Wallis one-way analysis of variance on ranks or 
Friedman repeated-measures analysis of variance on ranks) was performed. Specific tests are 
indicated in the Results section. Significance was accepted where P < 0.05.
RESULTS
Infinite Dose Studies
Figure 1 displays benzene permeation curves from all infinite dose epidermal exposures. 
These are pooled data displaying means and SDs of all 12 samples for each formulation. 
Solid lines represent the regression of the data with Eq. (3). These data show conformity 
with the characteristics of an archetypal infinite dose exposure: after a measurable lag time, 
a steady-state flux rate, characterized by the linear portion of the curve, is approached. Such 
linearity is achieved if a relatively constant concentration difference is maintained between 
donor and receptor.
Table 2 presents results from infinite dose epidermal permeation studies for benzene 
concentrations (vol%) of 0.8, 2.2, 3.6, 5.0, 10 and 100. Steady-state fluxes, permeability 
coefficients and lag times are listed. Correlations with Eq. (3) for all formulations were 
excellent (R2 > 0.99) and variances (< 32%) were reasonable for steady-state flux 
measurements. Permeability coefficients for formulations up to 10% benzene showed no 
significant differences (Kruskal–Wallis one-way analysis of variance on ranks). This finding 
indicates that steady-state flux is a near linear function of benzene concentration over this 
range.
For lag times, variances as high as 132% were observed and showed no significant 
differences for formulations up to 10% benzene (Kruskal–Wallis one-way analysis of 
variance on ranks). It appeared from an examination of the data in Figure 1 that a minor but 
noticeable falloff in benzene mass after 4 h may have contributed to a small lag time 
estimate with large variance. This observation led to a reanalysis of data considering only 
Frasch and Barbero Page 7
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2019 May 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the first 4 h of gasoline exposure. The calculations for JSS, kp and tlag from this analysis are 
shown in Table 2 in parentheses following the full 8 h data. These estimates of tlag ranged 
from 0.25 to 0.29 h with smaller variances (41–52%) (P < 0.05 compared with 8 h estimates 
for all except 2.2 vol%). On the other hand, estimates of JSS (and kp) from the 4 h exposure 
data were minimally (< 10%) and insignificantly greater than the 8 h estimates.
Figure 2 displays benzene permeation curves comparing human epidermis and full-thickness 
skin samples exposed to native gasoline (0.8 vol%). Again, pooled data are shown as means 
and SDs and solid lines represent regressions of the data with Eq. (3). These data also show 
excellent conformity with the permeation characteristics of an infinite dose exposure: 
correlations with Eq. (3) were excellent (R2 > 0.99).
Table 3 presents results comparing epidermis and full-thickness skin samples. Although 
these studies were derived from samples from a single human donor, the epidermal flux 
values did not differ significantly from the values reported in Table 2 for the same 
formulation, indicating that these skin samples are representative. The JSS (and kp) of 
epidermis are ~ 4.5-fold greater than those of the full-thickness specimens, while the lag 
time of the full-thickness skin was nearly 9-fold greater than the epidermis lag time. Both 
JSS and lag time measurement differences between the two skin preparations were highly 
significant (P < 0.001, two-tailed t-test).
Finite Dose Studies
Figure 3 displays pooled benzene permeation curves following three successive finite doses 
of 10 μl/cm2 of gasoline with 1.8 vol% benzene. Each dose therefore equals 157 μg benzene 
per cm2 exposure. Doses were administered 120 min apart; note that benzene penetration 
had leveled off at that time, indicative of near completion of the kinetic processes of 
absorption/evaporation. Solid lines connect the data as a guide to the eye.
Figure 4 shows box plots and individual (n = 12) scatter plots of benzene penetration for all 
six finite dose exposures over a two-day period. Benzene penetration following each dose 
was calculated as the amount at 120 min post exposure, minus the amount immediately 
preceding the exposure. Results are presented as total area-normalized benzene mass and as 
percentage of absorption of the applied benzene dose. Doses 5 and 6 exhibited significant 
differences compared with Dose 1 (P < 0.05, Friedman repeated-measures analysis of 
variance on ranks; multiple comparisons versus Dose 1 using Dunnett’s method). Also, the 
median of all day-1 exposures (0.104 μg/cm2) was significantly less than the median of all 
day-2 exposures (0.129 μg/cm2) (P < 0.05, Mann–Whitney rank-sum test).
Thermodynamic Activity
Figure 5 displays measured thermodynamic activity of benzene in benzene–gasoline 
mixtures. Benzene was miscible in gasoline at all concentrations. Activities are displayed as 
functions of mole fraction (A) and volume fraction (B) of benzene. Solid lines represent 
ideal solution behavior.
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DISCUSSION
The data described herein complement and extend previous studies on benzene permeation 
from gasoline and provide a reasonable explanation for apparent discrepancies from those 
studies.
Infinite Dose Studies
The soundness of the steady-state flux measurements reported here are supported by 
excellent correlations with Eq. (3) for all formulations (R2 > 0.99) and by variances < 32%.
Gasoline donor solution fluxes.—If steady-state flux is a linear function of benzene 
concentration, then the permeability coefficient of benzene in gasoline will be a constant 
(Eq. (4)). Our data show that this is the case for benzene concentrations up to 10% (Table 2): 
no significant differences were observed (Analysis of Variance) among kps in this 
concentration range. This is complemented by the finding that benzene–gasoline mixtures 
appear to form a nearly ideal solution over the entire concentration range (Figure 5): the 
magnitude of thermodynamic activity nearly equals the benzene mole fraction. For a fully 
miscible solution, activity is related to mole fraction as:
aBen = YBenXBen, (5)
where γBen is the activity coefficient. Thus, for an ideal solution, γBen = 1. When plotted as 
volume fraction (Figure 5b), curvature is observed (owing to differences in the ratios of 
density to MW of the two substances; see Eq. (2)) but for volume fractions up to at least 0.2, 
a linear approximation seems warranted. Therefore, a near linear relationship between 
steady-state flux and benzene concentration should be expected within this range. Our data 
support this expectation for concentrations up to 10 vol% (Figure 6).
Neat benzene fluxes.—However, the steady-state flux of neat benzene is less than what 
would be expected from linear extrapolation from the measured quantities up to 10% 
benzene. Based on results in Table 2, a Jss of ~ 1000 μg/cm2/h would be expected, while 566 
μg/cm2/h was measured. As a solvent, one might expect that neat benzene may reduce 
barrier function by solvating stratum corneum (SC) lipids. This appears not to be the case 
here and the reason for a lower than expected neat flux is unknown. The 16-h neat benzene 
data by Lodén5 show no sign of barrier reduction over a 16-h exposure, as evidenced by 
excellent linearity of the mass absorption profile, and Blank and McAuliffe6 also report no 
indication of barrier disruption to benzene flux.
Others have reported in vitro human neat benzene fluxes. The reported mean value of 99 
μg/cm2/h by Lodén5 was obtained using full-thickness skin which, as discussed 
subsequently, presents an un-physiologically high aqueous diffusion barrier that impedes 
transdermal flux. If one assigns the same factor of difference (4.5-fold) reported here for 
benzene flux from gasoline mixtures between epidermis and full-thickness skin, an 
estimated epidermal JSS of 447 μg/cm2/h results.
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The highest published human neat benzene mean flux value is of 2.11 μl/cm2/h by Blank 
and McAuliffe6 or 1844 μg/cm2/h. Others4,9,10 have questioned this based on an analysis of 
a single experiment displayed in Figure 1 in the study by Blank and McAuliffe.6 OSHA9 
estimated JSS from this curve to be 560 μg/cm2/h. We disagree with this claim of a 
“corrected” value and accept Blank and McAuliffe’s reported value derived, as they claim, 
“from multiple experiments”. However, do recognize the close similarity of the OSHA 
estimate with our measured mean of 566 μg/cm2/h.
Franz22,23 reported total mass absorbed from a range of neat loads applied to split-thickness 
skin. Only the two highest doses (270 and 520 μl/cm2) may have reached a steady state 
within Franz’s estimated exposure times of 1.5 and 3 h, respectively. Williams et al.4 
calculated fluxes of 260 and 330 μg/cm2/h but did not account for lag times in their 
estimations. For a lag time of 0.6 h (Table 2), Franz’s presumed steady-state fluxes (mass 
absorbed/(exposure time − lag time)) would be 329 and 544 μg/cm2/h.
A classic study by Hanke et al.,24 originally published in 1961, described human in vivo neat 
benzene exposures and reported a JSS of 400 μg/cm2/h, based on benzene loss over the 
exposure duration of 1.25–2 h. This flux calculation is thus time averaged and did not 
consider the contribution of a possible lag time. For a lag time of 0.6 h, this flux may be 
estimated (reported JSS × exposure duration)/(exposure duration − lag time) as 769 or 571 
μg/cm2/h, respectively.
These reports are the only studies from which a neat steady-state human benzene flux has 
either been reported or can be calculated. The calculated fluxes based on the data by 
Franz22,23 and Hanke et al.24 depend, of course, on the specific value of lag time used: 
shorter lag times will result in lower flux values. In the following section, we argue that a lag 
time range of 0.3–0.6 h is reasonable for neat benzene.
Lag time estimates.—Calculated lag times for gasoline exposures exhibited high 
variances. A potential issue with data analysis was identified in the Results section, and 
reanalysis yielded lag times of ~ 0.25 h with substantially less variance. This exercise points 
out the sensitivity of lag time measurements to small trends in the absorption rate over time. 
We posit 0.25 h as a more accurate estimate of lag time for benzene–gasoline mixtures. 
Apparently no other reports of epidermal benzene lag times from gasoline exposures in vitro 
are available for comparison. For full-thickness skin, our measured value 2.20 ± 1.01 h is in 
broad agreement with the range of mean values from 0.75 to 1.54 h by Adami et al.13 for 
three gasoline formulations.
The lag time of neat benzene measured here was 0.59 ± 0.15 h (Table 2). Although Blank 
and McAuliffe6 did not report lag times, extrapolation of the single neat benzene exposure 
shown in their Figure 1 suggests a value of ~ 0.5 h. Franz22,23 likewise did not report neat 
benzene lag times through their split-thickness skin, but analysis of the flux data in his 
Figure 3 suggests a value of ~ 0.3 h for pig skin. Franz reported that the times to maximum 
flux for human skin were ~ 2-fold larger than for pig skin, so a lag time of 0.5 h seems a 
reasonable estimate. We25 previously reported a human epidermal lag time of 0.15 h for 
benzene-saturated aqueous donor. However, direct comparisons in our laboratory26,27 of 
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permeation data for other compounds showed that neat donor lag times were ~ 1.5–3-fold 
longer than aqueous donor lag times (Frasch and Barbero27 present a discussion on this 
point). Thus all relevant published data suggest a reasonable estimate of 0.3–0.6 h for lag 
time of neat benzene through epidermal or split-thickness human skin.
Examination of previously reported flux discrepancies.—Our data clarify 
discrepancies in previously published in vitro data on steady-state benzene flux from 
gasoline exposure. Figure 6 compares our measurements with data from Blank and 
McAuliffe6 and from Adami et al.13 Solid circles represent our data (mean, SD) on steady-
state flux measurements with benzene concentration in gasoline, using human epidermis. 
The open circle is the reported value of 61.2 ± 25.5 μg/cm2/h by Blank and McAuliffe also 
using human epidermis. The solid square represents our value for full-thickness skin, and 
open squares are the data reported from Adami et al., who used full-thickness skin. (Adami 
et al. report benzene concentrations as wt%, which have been transformed here to vol% by 
multiplying by the ratio of gasoline-to-benzene densities.) The inset to Figure 6 shows these 
full-thickness data more clearly.
The dashed line in Figure 6 is a plot of proposed relationship by Petty et al.14 (their Eq. (11)) 
to predict steady-state benzene flux from concentration, based on regression of data from the 
literature:
JSS μg/cm
2/h = 20.4 × (benzene vol%)0.6616 . (6)
This relationship was proposed for the complete range of benzene concentrations up to 
100% and for any formulation containing benzene. However, our epidermis data in Figure 6 
demonstrate the superiority of a simple linear relationship (solid line) for gasoline with 
benzene concentrations up to 10 vol%. Based on these new data, we propose the following 
to be used to predict flux from gasoline with benzene concentrations that represent current 
and historical formulations:
JSS μg/cm
2/h = 1.4 + 10.6 × (benzene vol %), (7)
which correlates with current measurements with an R2 of 0.92. No data support the use of 
this relationship for > 10 vol% benzene.
As mentioned previously, discrepancies in measured benzene flux data from various organic 
mixtures has generated a heated debate surrounding the appropriate values to be used in 
estimating human dermal absorption for risk assessments. Data generated here should help 
to resolve the controversy for gasoline, as the discrepancies can be explained simply by 
considering the skin preparation technique. Flux measurements by Blank and McAuliffe6 
are in complete accord with our measured values using human epidermis, while those of 
Adami et al.13 are in complete accord with our values using full-thickness human skin. The 
thick (~1–2 mm), watery dermis impedes the penetration of the moderately liphophilic 
benzene. In vivo, the dermis is vascularized and convection (blood flow) is the primary 
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transport mechanism of chemicals that penetrate the epidermis, where transport is by 
diffusion. The in vitro full-thickness preparation thus presents a thick aqueous barrier that is 
not present in vivo. The isolated epidermis with sink conditions at the inner surface is the 
more appropriate in vitro model for the in vivo setting. In cases where in vitro studies are 
used to support dermal risk assessments, we propose that data from full-thickness skin 
measurement should not be used barring a proper accounting of this aqueous barrier. The 
same argument would question neat benzene flux value of 99 μg/cm2/h by Lodén5 as being 
artificially low.
Finite Dose Studies
The finite dose permeation data (Figures 3 and 4) show a fractional absorption of < 0.25% of 
the benzene from finite dose applications of 10 μl/cm2 gasoline left open to air. To enhance 
accuracy of quantification, benzene was added to gasoline to a final concentration of 1.8 vol
% for a benzene mass load of 157 μg/cm2. Less than 0.4 μg/cm2, with a median value of 
0.11 μg/cm2 (0.07% of the applied load) benzene was absorbed per exposure. To our 
knowledge, these are the only data that measure benzene permeation from finite dose 
gasoline exposures.
The total mass of chemical absorbed from finite doses depends on the rate of chemical 
evaporation compared with the rate of skin absorption.28,29 For in vitro studies, the 
evaporation rate of volatiles from the skin surface will vary with the dimensions of the donor 
cells (height:diameter ratio) (Frasch, unpublished) as well as the ambient air velocity30 
(here, 56–70 cm/s).
The gasoline exposure experiments undertaken herein under our laboratory conditions are in 
good agreement with previous studies using neat benzene under a variety of conditions, both 
in vitro and in vivo. Maibach and Anjo31 reported 0.17% absorption from ~ 4 μl/cm2 neat 
benzene applied to rhesus monkeys in vivo; Modjtahedi and Maibach32 observed 
absorptions of 0.07 and 0.13% from exposures of ~ 1 μl/cm2 applied to human forearms and 
palms, respectively. Franz22,23 reported 0.1 and 0.05% absorption of neat benzene in human 
in vitro and in vivo studies, respectively, while Gajjar and Kasting33 measured ~ 0.05% in 
vitro.
The initial sample interval of 15 min in our experiments was too long to calculate the rapidly 
changing benzene absorption rate: Gajjar and Kasting33 report maximum finite dose fluxes 
for neat benzene to occur within 5–20 min after exposure. For risk assessment, the total 
amount of chemical that is absorbed from a finite dose, rather than the non-steady absorption 
rate, is the crucial metric. Fitting of the data to an appropriate diffusion model33 could be 
performed if time-dependent flux estimates are needed.
Our finite dosing experiments covered only 1 gasoline load of 10 μl/cm2 and 1 benzene 
concentration. Different total mass absorptions would be expected from different loads. 
Gajjar and Kasting33 observed this for neat benzene loading but their cumulative 24-h 
percentage of absorption did not vary much (0.04–0.05%) over an 8-fold dose range. 
Therefore, total mass absorption from finite dose gasoline exposures may reasonably be 
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predicted from the fractional absorption measured here multiplied by the applied benzene 
mass load.
From multiple exposures over 2 days (Figure 4), there is some evidence of diminished 
barrier function. Doses 5 and 6 exceed dose 1 (P < 0.05, one-way analysis of variance on 
repeated measures), and the median of day-2 exposures (0.129 μg/cm2, combined doses 4–6) 
exceeded that of day-1 exposures (0.104 μg/cm2, combined doses 1–3) (P < 0.05, Mann–
Whitney rank-sum test). However, we cannot dismiss a nonspecific deterioration of the 
barrier over 2 days in an in vitro system.
Use of Data in Exposure Assessments
Results from these studies can be used to estimate benzene uptake from gasoline and neat 
benzene skin contact for exposure assessment purposes. The following are presented to 
demonstrate applications of data presented herein, and the authors make no claims regarding 
the realistic nature of these exposures.
Comparison with inhalation uptake rate.—These calculations are presented in order 
to compare the extent of dermal exposure that is necessary to equal the benzene uptake from 
inhalation. The OSHA benzene permissible exposure limit (PEL) for 8 h time-weighted 
average is 1 p.p.m., which equals 3.19 mg/m3 air concentration at 25 °C and 760 mmHg. 
The EPA34 recommends a breathing rate of 0.72 m3/h for light activity among adults. A 
pulmonary uptake fraction of 0.5 leads to 1.15 mg/h total benzene uptake rate through 
inhalation. For gasoline with 2 vol% benzene (17.5 μg/μl), Eq. (7) predicts a dermal steady-
state flux of 22.6 μg/cm2/h, so that a fully immersed skin surface area of 51 cm2 would 
result in equivalent steady-state systemic benzene uptake rate (3.19 mg/m3 × 0.72 m3/h × 0.5 
= 1.15 mg/h = 22.6 μg/cm2/h × 51 cm2). This area represents a small (< 4%) fraction of the 
EPA estimation of total surface area of adult male hands (1310 cm2).34
Transient immersion exposure.—Full-time immersion of skin in gasoline is an 
unrealistic exposure. Here we assume a 2 min immersion of both hands in gasoline with 2 
vol% benzene. Previous analyses35,36 have provided the theoretical underpinnings for the 
following equation that is commonly used in dermal risk assessments. Equation (8) 
quantifies total mass uptake (mT) from a transient immersion exposure to a highly volatile 
chemical, even if the exposure duration is significantly less than the membrane lag time for 
the chemical:
mT = JSSAexptexp, (8)
where Aexp and texp are exposed skin area and exposure duration. The assumption here is 
that the skin is thoroughly decontaminated following texp. For a 2-min exposure to the hands, 
this leads to an estimated systemic benzene uptake of about 1 mg of benzene (22.6 μg/cm2/h 
× 1310 cm2 × 2/60 h = 987 μg). If we assume that a film of 10 μl/cm2 of gasoline remains on 
skin after the 2-min exposure until evaporation, we can use the finite dose results with 
benzene absorption of 0.25% of applied dose to predict additional uptake of 573 μg (10 
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μl/cm2 × 1310 cm2 × 17.5 μg/μl × 0.25%/100% = 573 μg). This total benzene uptake of 1.56 
mg corresponds to that from ~ 1.4 h of inhalation uptake at 1 p.p.m.. Petty et al.14 estimate 
benzene uptake of 3.07 mg for a similar dermal exposure. The main difference is their 
calculated steady-state flux, based on Eq. (6), of 32.3 μg/cm2/h.
Another way of considering immersion exposures follows. Over the course of an 8-h day, 
any product of exposure surface and exposure duration equal to 407 cm2·h would be 
equivalent to the OSHA PEL pulmonary uptake of 9.2 mg (22.6 μg/cm2/h × 407 cm2·h = 9.2 
mg = 3.19 mg/m3 × 0.72 m3/h × 8 h × 0.5). For example, full immersion of both hands for 
0.31 h (~19 min) would be equivalent. This assumes thorough skin surface decontamination 
following the exposure; in the absence of which, dermal exposure will contribute more than 
respiratory.
Splash exposures.—Finite dose exposures are highly relevant to typical occupational 
and consumer scenarios and may contribute substantially to overall body burden.37 Skin 
exposures to small splashes of chemical, including gasoline, can go unnoticed,38 which 
highlights the importance of recognizing and quantifying these exposures. Because of the 
rapid evaporation rate of benzene, the total mass uptake from a splash or non-occluded finite 
dose exposure is expected to be small. If we assume 1 drop equals 50 μl, and each drop 
covers 5 cm2 of skin (10 μl/cm2), then, based on the finite dose results of 0.25% benzene 
absorption, total benzene uptake from 2 vol% gasoline (17.5 μg/μl) corresponds to 2.19 μg 
per drop (50 μl × 17.5 μg/μl × 0.25%/100% = 2.19 μg). Therefore, 526 drops per hour onto 
skin would be equivalent to the inhalation uptake at 1 p.p.m.
Galea et al.38 presented data on consumer exposures to diesel fuel from vehicle tank filling. 
Total exposure to both hands and forearms at the 90th percentile was 42.8 μg of fuel per cm2 
of exposure. The authors report total exposed skin area to be 990 cm2 for males. We assume 
2 vol% benzene (0.02 ml/ml) in gasoline and absorption of 0.25% of the exposure. For 
precise calculation, vol% is transformed to mass%: 0.02 ml benzene/ml gasoline × 874 μg 
benzene/μl benzene÷733 μg gasoline/μl gasoline = 0.024 μg benzene/μg gasoline. Total 
systemic benzene uptake would therefore be 2.54 μg (42.8 μg gasoline/cm2 × 990 cm2 × 
0.024 μg benzene/μg gasoline × (0.25/100)% = 2.54 μg benzene). This corresponds to the 
inhalational uptake from 1 p.p.m. benzene vapor for ~ 8 s (1.15 mg/h × 1 h/60 min × 1 
min/60 s × 7.95s = 2.54 μg).
Summary and Limitations
The present studies were designed to expand upon and interpret previous measurements of 
benzene permeation from gasoline and neat benzene. Using HEM, we found steady-state 
flux rates to be a linear function of the concentration of benzene in gasoline from 0.8 to 10 
vol%. This linearity is expected based on our finding that benzene-gasoline mixtures behave 
as a near-ideal solution over the entire range of benzene concentrations. Steady-state fluxes 
through full-thickness skin from native gasoline containing 0.8 vol% benzene were ~ 4.5-
fold less than the fluxes through epidermis. Measured steady-state fluxes at 0.8 and 5 vol% 
were similar to those reported by others using full-thickness (Adami et al) and epidermis 
(Blank and McAuliffe) membranes, respectively. Finite dose exposures to repeated single 
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volumetric loads of 10 μl/cm2 of gasoline, corresponding to benzene mass loads of 157 
μg/cm2, demonstrated that < 0.25% of the total applied benzene dose was absorbed 2 h after 
the exposures. A median value of ~ 0.07% is in line with neat benzene data reported by 
others, both in vitro and in vivo. Applications of the data presented here in dermal exposure 
assessments is presented through several examples relevant to both occupational and 
consumer exposures.
These data are in vitro and so caution applies to their application to the in vivo setting. The 
experiments comparing full thickness with epidermis used skin samples (n = 12 each) 
derived from only one human donor and may not be representative of others. The finite dose 
experiments tested only one loading of one concentration; a broader range of studies would 
be desirable. Meaningful non-steady-state flux measurements would be possible with shorter 
sampling intervals during the kinetic phase. Only absorbed amounts were quantified and we 
did not measure evaporated mass from the diffusion cell apparatus or mass of benzene 
remaining in the skin following exposures. Therefore, a full accounting for disposition of the 
applied loads could not be made.
CONCLUSIONS
The data presented here compliment and extend previous studies on benzene dermal uptake 
from gasoline and neat benzene exposures. These studies provide a reasonable explanation 
of previously published conflicting benzene steady-state flux values and provide a 
framework for dermal exposure assessments to gasoline from current and historic gasoline 
formulations. Finite dose gasoline exposure results are presented for the first time, and 
repeat dosing suggests only minor alterations of the skin barrier under the conditions tested 
here.
These results may be used to estimate the extent to which benzene uptake can be expected 
from dermal exposures. On an area-normalized basis, extended immersion-type exposures 
lead to the greatest uptake, short-term exposures lead to less uptake and splash-type 
exposures are expected to contribute to the least uptake, owing to the volatility of benzene.
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Figure 1. 
Pooled benzene epidermal permeation curves (mean ± SD, n = 12 each) from infinite doses 
of gasoline at the indicated benzene vol% (100 vol% is neat benzene). Solid lines are 
regressions of mean data with Eq. (3).
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Figure 2. 
Pooled permeation curves (mean ± SD, n = 12 each from same human donor) using 
epidermis and full-thickness skin exposed to infinite dose gasoline (0.8 vol% benzene). 
Solid lines are regressions of mean data with Eq. (3).
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Figure 3. 
Cumulative benzene permeation from three successive exposures to gasoline (1.8 vol% 
benzene) dosed at 10 μl/cm2 (157 μg/cm2 of benzene). Pooled (mean ± SD n = 12) data 
show accumulated mass detected in receptor compartments.
Frasch and Barbero Page 20
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2019 May 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. 
Two-day, multiple-dose benzene permeation from gasoline dosed at 10 μl/cm2 (157 μg/cm2 
benzene). Axes display mass of benzene detected in receptor fluid (left) and percentage of 
absorption of applied benzene dose (right) 120 min after dosing. Plots show differences in 
benzene absorption from previous exposure. Box plots show median, 25th and 75th 
percentiles and 10th and 90th percentiles. Scatter plots to the right of boxes show individual 
data points for all 12 skin samples. *Significant (P < 0.05) compared with Dose 1 (Friedman 
Repeated-Measures ANOVA). Also, median Day 1 values were less than median Day 2 
values (P < 0.05, Mann–Whitney rank-sum test).
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Figure 5. 
Benzene thermodynamic activity in gasoline with benzene concentration as mole fraction (a) 
and as volume fraction (b). Each concentration was tested three times (nine times for neat 
benzene). Solid lines indicate ideal solution behavior.
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Figure 6. 
Comparison of steady-state benzene flux measurements from gasoline among different 
studies. Solid circles represent data herein using human epidermis. White circle is data from 
Blank and McAullife6 using human epidermis. Error bars (SD) are one-sided for clarity. 
Black square is data herein using full-thickness skin. White squares are data from Adami et 
al.15 using full-thickness skin. Solid line is linear correlation (R2 = 0.92) with our epidermis 
data (excluding neat benzene). Dashed line is the proposed relationship by Petty et al.16 
Inset is enlarged section of the plot.
Frasch and Barbero Page 23
J Expo Sci Environ Epidemiol. Author manuscript; available in PMC 2019 May 23.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Frasch and Barbero Page 24
Table 1.
Results of gasoline analysis undertaken by Bureau Veritas North America.
Method Test Result (Wt%/Vol%)
ASTM D5580 Benzene 0.93/0.78
Toluene 6.56/5.57
Ethylbenzene 2.34/1.99
p/m-Xylenes 6.04/5.15
o-Xylene 2.12/1.77
C9+Aromatics 9.30/7.86
Total Aromatics 27.29/23.12
ASTM D6730 Paraffins 5.477/6.370
Isoparaffins 46.707/50.201
Olefins 4.746/5.064
Naphthenes 3.311/3.173
Naphthalenes 0.212/0.152
Aromatics 28.092/23.614
C5 Hydrocarbons (HC) 9.210/10.742
C14+HC 0.085/0.082
Unknown 0.560/0.586
Benzene 0.988/0.824
Toluene 6.684/5.652
Oxygenates 11.022/10.911
Concentrations of substances are listed according to the cited analytical method.
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Table 3.
Skin permeation of benzene from gasoline through epidermal membranes and full-thickness skin.
Skin type JSS (μg/cm2/h) kp (10−3 cm/h) tlag (h)
Epidermis 8.22 ± 0.61 1.18 ± 0.09 0.25 ± 0.06
Full thickness 1.82 ± 0.44a 0.260 ± 0.06a 2.20 ± 1.01a
Twelve samples of both were studied from one human donor.
aSignificantly (P < 0.001) different compared with epidermis (two-tailed t-test).
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